Stimuli‐responsive crosslinked nanomedicine for cancer treatment

X Xue, H Qu, Y Li - Exploration, 2022 - Wiley Online Library
Nanomedicines are attractive paradigms to deliver drugs, contrast agents,
immunomodulators, and gene editors for cancer therapy and diagnosis. However, the …

[HTML][HTML] Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression

M Ashrafizadeh, S Mirzaei, MH Gholami… - Carbohydrate …, 2021 - Elsevier
An important motivation for the use of nanomaterials and nanoarchitectures in cancer
therapy emanates from the widespread emergence of drug resistance. Although doxorubicin …

[HTML][HTML] Biomacromolecules as carriers in drug delivery and tissue engineering

Y Zhang, T Sun, C Jiang - Acta Pharmaceutica Sinica B, 2018 - Elsevier
Natural biomacromolecules have attracted increased attention as carriers in biomedicine in
recent years because of their inherent biochemical and biophysical properties including …

Polysaccharide‐based controlled release systems for therapeutics delivery and tissue engineering: from bench to bedside

T Miao, J Wang, Y Zeng, G Liu, X Chen - Advanced science, 2018 - Wiley Online Library
Polysaccharides or polymeric carbohydrate molecules are long chains of monosaccharides
that are linked by glycosidic bonds. The naturally based structural materials are widely …

Polysaccharide-based nanoparticles for theranostic nanomedicine

M Swierczewska, HS Han, K Kim, JH Park… - Advanced drug delivery …, 2016 - Elsevier
Polysaccharides are natural biological molecules that have numerous advantages for
theranostics, the integrated approach of therapeutics and diagnostics. Their derivable …

Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment

HA Hussein, MA Abdullah - Applied Nanoscience, 2022 - Springer
Drug delivery is a method to control the delivery of pharmaceutical compound to achieve
therapeutic effect in humans or animals. Several active pharmaceutical ingredients (APIs) …

[HTML][HTML] Hyaluronic acid-coated nanomedicine for targeted cancer therapy

K Kim, H Choi, ES Choi, MH Park, JH Ryu - Pharmaceutics, 2019 - mdpi.com
Hyaluronic acid (HA) has been widely investigated in cancer therapy due to its excellent
characteristics. HA, which is a linear anionic polymer, has biocompatibility, biodegradability …

Visible light-induced crosslinking and physiological stabilization of diselenide-rich nanoparticles for redox-responsive drug release and combination chemotherapy

S Zhai, X Hu, Y Hu, B Wu, D Xing - Biomaterials, 2017 - Elsevier
Undesired physiological instability of nanocarriers and premature drug leakage during
blood circulation result in compromised therapeutic efficacy and severe side effects, which …

Hyaluronic acid–based activatable nanomaterials for stimuli‐responsive imaging and therapeutics: beyond CD44‐mediated drug delivery

KY Choi, HS Han, ES Lee, JM Shin… - Advanced …, 2019 - Wiley Online Library
There is a rapidly increasing interest in developing stimuli‐responsive nanomaterials for
treating a variety of diseases. By enabling the activation of function locally at the sites of …

Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy

JM Wickens, HO Alsaab, P Kesharwani, K Bhise… - Drug discovery today, 2017 - Elsevier
Highlights•CD44 receptor is overexpressed in highly invasive stem-like cancer cells
(SLCS).•CD44 receptors have high affinity toward hyaluronic acid (HA) binding.•Recent …